Liver Treatment Market 2025 by Product Type, Power Source, End-use and Sales Channel | The Insight Partners

Liver Treatment Market to 2025 – Global Analysis and Forecasts by Disease (Cirrhosis, Hepatitis, Cancer and Other Diseases); Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities); and Geography

Publication Month: Sep 2018 | Report Code: TIPMD00002089 | No. of Pages: 115 | Category: Medical Device | Status: Published

The global liver treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8 Mn in 2017. The market is estimated to grow with a CAGR of 4.6% from 2018-2025.

Liver treatment market is segmented into disease and imaging modality. On the basis of disease, the market is segmented into cirrhosis, hepatitis, cancer and other diseases. The liver treatment market is segmented as, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and other modalities, based on imaging modality.

Liver carries out an essential function of digesting food as well as elimination of toxic substances from the body. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol, eventually leading to fatal condition called, liver cirrhosis. Liver diseases can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound. Key factors driving the market are the increase in the number of liver disease cases, technological advancements in imaging and rising geriatric population at a higher risk of developing liver disease.

The report would be of an interest to various stakeholders operating in the liver treatment market. These stakeholders include healthcare institutes, research institutes, liver treatment product manufacturers and vendors, research consulting firms, liver treatment service providers, distributors and others.

The objective of the study is to describe, define, and forecast the liver treatment market by disease and imaging modality, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall liver treatment market.

The report analyzes factors affecting market from both demand and supply side and further evaluates liver treatment market dynamics effecting the liver treatment market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

Some of the prominent players operating in liver treatment market are General Electric, Koninklijke Philips N.V., Siemens AG, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, and Cura Healthcare. The market players are indulged into development of novel and innovative products to cater the demands of users in the liver treatment market. For instance, in March 2018, GE Healthcare launched LOGIQ. This system offers 48 times the data throughput and 10 times the processing power of the existing systems and is capable of spotting lesions in the liver, thus enabling better diagnosis of the medical condition

TABLE OF CONTENTS

1. INTRODUCTION 14
1.1 SCOPE OF THE STUDY 14
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 14

2. GLOBAL LIVER TREATMENT MARKET – KEY TAKEAWAYS 15

3. GLOBAL LIVER TREATMENT MARKET – MARKET LANDSCAPE 17
3.1 OVERVIEW 17
3.2 MARKET SEGMENTATION 17
3.2.1 Global Liver Treatment Market – By Disease 18
3.2.2 Global Liver Treatment Market – By Imaging Modality 18
3.2.3 Global Liver Treatment Market – By Geography 19

4. GLOBAL LIVER TREATMENT MARKET – KEY MARKET DYNAMICS 20
4.1 KEY MARKET DRIVERS 20
4.1.1 Increasing Prevalence of Liver Diseases 20
4.1.2 Increasing Geriatric Population 20
4.1.3 Technological Advancements in Imaging Techniques 21
4.2 KEY MARKET RESTRAINTS 21
4.2.1 Stringent Regulatory Validation Requirement 21
4.2.2 High Cost of Imaging Techniques 21
4.3 KEY MARKET OPPORTUNITIES 22
4.3.1 Partnerships and Collaborations Between Market Players 22
4.3.2 Increasing Healthcare Expenditures in Emerging Markets 22
4.4 FUTURE TRENDS 23
4.4.1 Increasing Use of Hybrid Systems for Imaging 23
4.5 IMPACT ANALYSIS 24

5. LIVER TREATMENT MARKET –GLOBAL ANALYSIS 25
5.1 LIVER TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 25
5.2 GLOBAL LIVER TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 25
5.3 EXPERT OPINIONS 26

6. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY DISEASES 27
6.1 OVERVIEW 27
6.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE 2017 & 2025 (%) 27
6.3 CANCER MARKET 28
6.3.1 Overview 28
6.3.2 Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn) 28
6.4 HEPATITIS MARKET 29
6.4.1 Overview 29
6.4.2 Global Hepatitis Market Revenue and Forecasts to 2025 (US$ Mn) 30
6.5 CIRRHOSIS MARKET 31
6.5.1 Overview 31
6.5.2 Global Cirrhosis Market Revenue and Forecasts to 2025 (US$ Mn) 31
6.6 OTHER DISEASES MARKET 32
6.6.1 Overview 32
6.6.2 Global Other Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 32

7. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY IMAGING MODALITY 33
7.1 OVERVIEW 33
7.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY 2017 & 2025 (%) 33
7.3 COMPUTED TOMOGRAPHY (CT) MARKET 34
7.3.1 Overview 34
7.3.2 Global Computed Tomography (CT) Market Revenue and Forecasts to 2025 (US$ Mn) 34
7.4 MAGNETIC RESONANCE IMAGING (MRI) MARKET 35
7.4.1 Overview 35
7.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2025 (US$ Mn) 35
7.6 ULTRASOUND MARKET 36
7.6.1 Overview 36
7.6.2 Global Ultrasound Market Revenue and Forecasts to 2025 (US$ Mn) 36
7.7 OTHER IMAGING MODALITIES MARKET 37
7.7.1 Overview 37
7.7.2 Global Other Imaging Modalities Market Revenue and Forecasts to 2025 (US$ Mn) 37

8. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 38
8.1 OVERVIEW 38
8.2 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
8.3 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 39
8.4 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 40
8.5 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 40
8.6 US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
8.6.1 US Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 42
8.6.2 US Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 42
8.6.3 US Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 43
8.7 CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
8.7.1 Canada Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 44
8.7.2 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 45
8.7.3 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 45
8.8 MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
8.8.1 Mexico Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 46
8.8.2 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 47
8.8.3 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 47

9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 48
9.1 OVERVIEW 48
9.2 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
9.3 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
9.4 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 50
9.5 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
9.6 GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
9.6.1 Germany Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 51
9.6.2 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
9.6.3 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 52
9.7 FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
9.7.1 France Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 53
9.7.2 France Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
9.7.3 France Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 54
9.8 UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
9.8.1 UK Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 55
9.8.2 UK Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56
9.8.3 UK Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 56

10. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 57
10.1 OVERVIEW 57
10.2 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
10.3 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 58
10.4 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 59
10.5 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 59
10.6 JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
10.6.1 Japan Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 60
10.6.2 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 61
10.6.3 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 61
10.7 CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
10.7.1 China Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 62
10.7.2 China Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 63
10.7.3 China Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 63
10.8 INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
10.8.1 India Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 64
10.8.2 India Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 65
10.8.3 India Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 65

11. MIDDLE EAST AND AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 66
11.1 OVERVIEW 66
11.2 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
11.3 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 67
11.4 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 68
11.5 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 68
11.6 UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
11.6.1 UAE Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 69
11.6.2 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 70
11.6.3 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 70
11.7 SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
11.7.1 Saudi Arabia Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 71
11.7.2 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
11.7.3 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 72
11.8 SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
11.8.1 South Africa Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 73
11.8.2 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
11.8.3 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 74

12. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 75
12.1 OVERVIEW 75
12.2 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
12.3 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
12.4 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 77
12.5 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
12.6 BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
12.6.1 Brazil Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 78
12.6.2 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 79
12.6.3 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 79

13. LIVER TREATMENT MARKET –KEY COMPANY PROFILES 80
13.1 GENERAL ELECTRIC 80
13.1.1 Key Facts 80
13.1.2 Business Description 80
13.1.3 Financial Overview 81
13.1.4 Product Portfolio 81
13.1.5 SWOT Analysis 82
13.1.6 Key Developments 82
13.2 KONINKLIJKE PHILIPS N.V. 83
13.2.1 Key Facts 83
13.2.2 Business Description 83
13.2.3 Financial Overview 84
13.2.4 Product Portfolio 84
13.2.5 SWOT Analysis 85
13.2.6 Key Developments 85
13.3 SIEMENS AG 86
13.3.1 Key Facts 86
13.3.2 Business Description 86
13.3.3 Financial Overview 87
13.3.4 Product Portfolio 87
13.3.5 SWOT Analysis 88
13.3.6 Key Developments 88
13.4 CANON MEDICAL SYSTEMS CORPORATION 89
13.4.1 Key Facts 89
13.4.2 Business Description 89
13.4.3 Financial Overview 90
13.4.4 Product Portfolio 90
13.4.5 SWOT Analysis 91
13.4.6 Key Developments 91
13.5 HITACHI, LTD 92
13.5.1 Key Facts 92
13.5.2 Business Description 92
13.5.3 Financial Overview 92
13.5.4 Product Portfolio 93
13.5.5 SWOT Analysis 93
13.5.6 Key Developments 94
13.6 ELEKTA AB (PUB) 95
13.6.1 Key Facts 95
13.6.2 Business Description 95
13.6.3 Financial Overview 96
13.6.4 Product Portfolio 96
13.6.5 SWOT Analysis 97
13.6.6 Key Developments 97
13.7 NEUSOFT CORPORATION 98
13.7.1 Key Facts 98
13.7.2 Business Description 98
13.7.3 Financial Overview 99
13.7.4 Product Portfolio 99
13.7.5 SWOT Analysis 100
13.7.6 Key Developments 100
13.8 SAMSUNG HEALTHCARE 101
13.8.1 Key Facts 101
13.8.2 Business Description 101
13.8.3 Financial Overview 102
13.8.4 Product Portfolio 102
13.8.5 SWOT Analysis 102
13.8.6 Key Developments 102
13.9 BPL MEDICAL TECHNOLOGIES 103
13.9.1 Key Facts 103
13.9.2 Business Description 103
13.9.3 Financial Overview 103
13.9.4 Product Portfolio 103
13.9.5 SWOT Analysis 104
13.9.6 Key Developments 104
13.10 CURA HEALTHCARE 105
13.10.1 Key Facts 105
13.10.2 Business Description 105
13.10.3 Financial Overview 105
13.10.4 Product Portfolio 106
13.10.5 SWOT Analysis 106
13.10.6 Key Developments 107

14. APPENDIX 108
14.1 ABOUT THE INSIGHT PARTNERS 108
14.2 GLOSSARY OF TERMS 109
14.3 METHODOLOGY 111
14.3.1 Coverage 112
14.3.2 Secondary Research 113
14.3.3 Primary Research 113

LIST OF TABLES

TABLE 1. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 40
TABLE 2. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 41
TABLE 3. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 43
TABLE 4. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 44
TABLE 5. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 46
TABLE 6. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 46
TABLE 7. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 48
TABLE 8. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 48
TABLE 9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 50
TABLE 10. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 51
TABLE 11. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 53
TABLE 12. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 53
TABLE 13. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 55
TABLE 14. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 55
TABLE 15. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 57
TABLE 16. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 57
TABLE 17. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 18. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 60
TABLE 19. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 20. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 62
TABLE 21. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
TABLE 22. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 64
TABLE 23. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
TABLE 24. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 66
TABLE 25. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 68
TABLE 26. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 69
TABLE 27. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 71
TABLE 28. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 71
TABLE 29. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 73
TABLE 30. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 73
TABLE 31. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 75
TABLE 32. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 75
TABLE 33. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 77
TABLE 34. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 78
TABLE 35. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 80
TABLE 36. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 80
TABLE 37. GLOSSARY OF TERMS, LIVER TREATMENT MARKET 110

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 16
FIGURE 2. GLOBAL LIVER TREATMENT MARKET BY DISEASE, MARKET SHARE (%), 2017 17
FIGURE 3. GLOBAL LIVER TREATMENT MARKET BY IMAGING MODALITY, MARKET SHARE (%), 2017 17
FIGURE 4. LIVER TREATMENT MARKET SEGMENTATION 18
FIGURE 5. LIVER TREATMENT SEGMENTATION, BY REGION 19
FIGURE 6. LIVER TREATMENT MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 25
FIGURE 7. GLOBAL LIVER TREATMENT MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 26
FIGURE 8. GLOBAL LIVER TREATMENT MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 27
FIGURE 9. GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE, 2017 & 2025 (%) 28
FIGURE 10. GLOBAL CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 29
FIGURE 11. GLOBAL HEPATITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 31
FIGURE 12. GLOBAL CIRRHOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 32
FIGURE 13. GLOBAL OTHER DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 33
FIGURE 14. GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY, 2017 & 2025 (%) 34
FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
FIGURE 16. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
FIGURE 17. GLOBAL ULTRASOUND MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 37
FIGURE 18. GLOBAL OTHER IMAGING MODALITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
FIGURE 19. NORTH AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 39
FIGURE 20. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 21. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 41
FIGURE 22. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 23. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 24. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 25. EUROPE LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 49
FIGURE 26. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 27. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 51
FIGURE 28. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 29. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 30. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 31. ASIA PACIFIC LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 58
FIGURE 32. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 33. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
FIGURE 34. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 35. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 36. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 37. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 67
FIGURE 38. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 39. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
FIGURE 40. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 41. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
FIGURE 42. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 43. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 76
FIGURE 44. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
FIGURE 45. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 78
FIGURE 46. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79

The List of Companies

1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. CANON MEDICAL SYSTEMS CORPORATION
5. Hitachi, Ltd
6. Elekta AB (pub)
7. Neusoft Corporation
8. Samsung Healthcare
9. BPL Medical Technologies
10. Cura Healthcare

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liver treatment market.

-Highlights key business priorities in order to assist companies to realign their business strategies.

-The key findings and recommendations highlight crucial progressive industry trends in the global liver treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Select License Type
USD $4550
USD $6550
USD $8550